Pure Global

The Incidence of Treatment-requiring Retinopathy of Prematurity in Greece - Trial NCT05099588

Access comprehensive clinical trial information for NCT05099588 through Pure Global AI's free database. This phase not specified trial is sponsored by Aristotle University Of Thessaloniki and is currently Completed. The study focuses on Retinopathy of Prematurity. Target enrollment is 43 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT05099588
Completed
other
Trial Details
ClinicalTrials.gov โ€ข NCT05099588
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
The Incidence of Treatment-requiring Retinopathy of Prematurity in Greece
The Incidence of Treatment-requiring Retinopathy of Prematurity in Greece: a Multicenter Prospective Cohort Study

Study Focus

Other: observational study

Observational

other

Sponsor & Location

Aristotle University Of Thessaloniki

Thessalonรญki, Greece

Timeline & Enrollment

N/A

Jun 01, 2020

Jan 15, 2023

43 participants

Primary Outcome

The incidence of treatment-requiring ROP (TR-ROP) in Greece

Summary

A prospective observational study of the incidence of treatment-requiring ROP (TR-ROP), at a
 national level, in Greece.

ICD-10 Classifications

Retinopathy of prematurity
Other proliferative retinopathy
Background retinopathy and retinal vascular changes
Diabetic retinopathy
Retinal disorder, unspecified

Data Source

ClinicalTrials.gov

NCT05099588

Non-Device Trial